Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 104201-104250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03573089
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
NARecruiting
3,600 participants
Started: Dec 10, 2019 · Completed: Dec 31, 2028
2 conditions5 sponsors115 locations
NCT03999788
miR-142-3p as Potential Biomarker of Synaptopathy in MS
NARecruiting
1,000 participants
Started: Dec 10, 2019 · Completed: Dec 28, 2025
2 conditions1 sponsor1 location
NCT04635657
Cognitive Status After Removal of Skull Base Meningioma
N/ARecruiting
50 participants
Started: Dec 10, 2019 · Completed: Dec 31, 2024
7 conditions1 sponsor1 location
NCT03809728
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
NARecruiting
1,000 participants
Started: Dec 10, 2019 · Completed: Dec 10, 2034
3 conditions1 sponsor1 location
NCT04184700
Epigenetic Effects in Children With Cow's Milk Allergy Treated With Different Formulas
NARecruiting
90 participants
Started: Dec 10, 2019 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT03822442
MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients
N/ARecruiting
200 participants
Started: Dec 10, 2019 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04195503
Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma
NAEnrolling by invitation
10 participants
Started: Dec 10, 2019 · Completed: Dec 31, 2034
1 condition1 sponsor1 location
NCT04059172
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
EARLY_PHASE1Recruiting
375 participants
Started: Dec 10, 2019 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT05653596
VR-based Intervention for Cognitive Restoration
NARecruiting
200 participants
Started: Dec 10, 2019 · Completed: Jul 31, 2025
3 conditions1 sponsor1 location
NCT04172038
SMART Stepped Care Management for Low Back Pain in the Military Health System
NAActive, not recruiting
850 participants
Started: Dec 9, 2019 · Completed: Jul 31, 2025
4 conditions6 sponsors4 locations
NCT04164641
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
NARecruiting
69 participants
Started: Dec 9, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04324762
Implementation of Ultrasound Guided Central Venous Catheter Confirmation Protocol
N/ARecruiting
120 participants
Started: Dec 9, 2019 · Completed: Dec 31, 2023
3 conditions1 sponsor1 location
NCT04095351
Connective Tissue Diseases and Lung Manifestations
N/ARecruiting
120 participants
Started: Dec 9, 2019 · Completed: Oct 1, 2034
3 conditions2 sponsors1 location
NCT04135794
Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)
N/ARecruiting
500 participants
Started: Dec 9, 2019 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT04476199
Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT
PHASE2Active, not recruiting
100 participants
Started: Dec 9, 2019 · Completed: Jun 30, 2025
1 condition1 sponsor25 locations
NCT04189029
PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study
N/AActive, not recruiting
175 participants
Started: Dec 9, 2019 · Completed: Dec 31, 2025
2 conditions13 sponsors1 location
NCT04204707
Patient Reported Outcomes After Surgery for Rectal Endometriosis
N/AActive, not recruiting
294 participants
Started: Dec 9, 2019 · Completed: Mar 31, 2025
4 conditions2 sponsors2 locations
NCT07154381
Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis
N/ARecruiting
25 participants
Started: Dec 9, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04227678
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
NARecruiting
16 participants
Started: Dec 9, 2019 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT04061603
iCLAS™ for Persistent Atrial Fibrillation
NAActive, not recruiting
200 participants
Started: Dec 9, 2019 · Completed: Aug 30, 2024
1 condition1 sponsor21 locations
NCT03816358
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
PHASE1Active, not recruiting
74 participants
Started: Dec 9, 2019 · Completed: Jan 31, 2026
4 conditions1 sponsor45 locations
NCT04166877
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
PHASE4Recruiting
156 participants
Started: Dec 7, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04192981
GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases
PHASE1Active, not recruiting
21 participants
Started: Dec 6, 2019 · Completed: Dec 31, 2026
2 conditions2 sponsors9 locations
NCT04238949
Community Health Workers in Pediatric Patients With Newly Diagnosed Type 1 Diabetes
NAActive, not recruiting
28 participants
Started: Dec 6, 2019 · Completed: Jan 31, 2026
5 conditions2 sponsors1 location
NCT03881098
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
NARecruiting
240 participants
Started: Dec 6, 2019 · Completed: Jan 31, 2026
1 condition2 sponsors2 locations
NCT04142606
LUMIERE on the FETUS
N/ARecruiting
1,500 participants
Started: Dec 6, 2019 · Completed: Jun 30, 2027
1 condition3 sponsors1 location
NCT03836209
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
PHASE2Active, not recruiting
181 participants
Started: Dec 6, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors44 locations
NCT03494959
Pentaglobin in CRE and PA Neutropenic Infections
PHASE2Active, not recruiting
120 participants
Started: Dec 6, 2019 · Completed: May 31, 2025
1 condition1 sponsor20 locations
NCT04197414
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
N/ARecruiting
3,000 participants
Started: Dec 6, 2019 · Completed: Dec 31, 2029
4 conditions1 sponsor1 location
NCT03930121
Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia
NAActive, not recruiting
130 participants
Started: Dec 6, 2019 · Completed: Aug 4, 2026
2 conditions1 sponsor19 locations
NCT04092660
Increasing the Use of an Anti-snoring Mouth Guard (Mandibular Advancement Appliance) to Prevent Upper Airway Collapse During Sleep in Patients With Obstructive Sleep Apnoea.
NARecruiting
56 participants
Started: Dec 6, 2019 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT03970538
PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
NAActive, not recruiting
105 participants
Started: Dec 6, 2019 · Completed: Feb 28, 2025
12 conditions1 sponsor21 locations
NCT04220827
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
PHASE1Active, not recruiting
27 participants
Started: Dec 6, 2019 · Completed: Oct 30, 2028
17 conditions2 sponsors1 location
NCT04125277
The SONImage Study
NAActive, not recruiting
100 participants
Started: Dec 5, 2019 · Completed: Jul 31, 2025
1 condition3 sponsors2 locations
NCT04225455
The Use of the Dexcom G6® in Commercial Pilots With Insulin-treated Diabetes
N/AActive, not recruiting
17 participants
Started: Dec 5, 2019 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT02846571
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
PHASE1/PHASE2Recruiting
2 participants
Started: Dec 5, 2019 · Completed: Dec 31, 2027
1 condition3 sponsors2 locations
NCT04097652
Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke
PHASE1Recruiting
9 participants
Started: Dec 5, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03748446
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
EARLY_PHASE1Recruiting
20 participants
Started: Dec 5, 2019 · Completed: Dec 1, 2026
2 conditions1 sponsor1 location
NCT04990726
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
N/AActive, not recruiting
126 participants
Started: Dec 5, 2019 · Completed: Feb 2, 2027
8 conditions1 sponsor1 location
NCT03961334
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention
PHASE3Recruiting
620 participants
Started: Dec 5, 2019 · Completed: Jan 31, 2026
1 condition2 sponsors14 locations
NCT04097470
Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients
PHASE2Active, not recruiting
140 participants
Started: Dec 5, 2019 · Completed: Nov 30, 2026
1 condition2 sponsors37 locations
NCT03998540
Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy
N/ARecruiting
50 participants
Started: Dec 5, 2019 · Completed: May 5, 2025
3 conditions1 sponsor1 location
NCT03736863
A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
PHASE2Recruiting
147 participants
Started: Dec 5, 2019 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT03480334
Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy
PHASE2Active, not recruiting
26 participants
Started: Dec 5, 2019 · Completed: May 4, 2025
1 condition1 sponsor1 location
NCT04179383
Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome
NARecruiting
225 participants
Started: Dec 5, 2019 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT04283890
PHP and Immunotherapy in Metastasized UM
PHASE1/PHASE2Active, not recruiting
83 participants
Started: Dec 4, 2019 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT04034927
Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer
PHASE2Active, not recruiting
61 participants
Started: Dec 4, 2019 · Completed: Feb 21, 2026
14 conditions2 sponsors20 locations
NCT03976843
Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
PHASE2Active, not recruiting
175 participants
Started: Dec 4, 2019 · Completed: Nov 19, 2027
1 condition2 sponsors6 locations
NCT04073966
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
N/ARecruiting
15 participants
Started: Dec 4, 2019 · Completed: Sep 15, 2026
4 conditions1 sponsor1 location
NCT04068623
Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients
N/ARecruiting
90 participants
Started: Dec 4, 2019 · Completed: Oct 31, 2032
1 condition1 sponsor1 location